Literature DB >> 624595

Establishment of Marek's disease lymphoblastoid cell lines from transplantable versus primary lymphomas.

B W Calnek, K K Murthy, K A Schat.   

Abstract

Six new Marek's disease (MD) lymphoblastoid cell lines were established in vitro by cultivation in a medium containing 2-mercaptoethanol (2-ME). Attempts using primary lymphoma cells were generally unsuccessful; only one of 28 lymphomas yielded a cell line and that one came from an experimentally immunosuppressed chicken. In contrast, two of seven low-passage, and two of two established MD transplantable lymphomas grew readily in vitro. A sixth line was obtained using buffy coat cells from a leukemic chicken. It was concluded that the use of transplantable tumor cells and a medium containing 2-ME provided a combination highly suited to the establishment of cell lines from MD.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624595     DOI: 10.1002/ijc.2910210117

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Use of chicken cell line LSCC-H32 for titration of animal viruses and exogenous chicken interferon.

Authors:  S Roth; O R Kaaden
Journal:  Appl Environ Microbiol       Date:  1985-03       Impact factor: 4.792

3.  Cultivation of avian rotaviruses in chicken lymphocytes and lymphoblastoid cell lines.

Authors:  K A Schat; T J Myers
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus.

Authors:  K A Schat; B W Calnek
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

5.  Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines.

Authors:  B W Calnek; W R Shek; K A Schat
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

6.  In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.

Authors:  K A Schat; K K Murthy
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

7.  In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes.

Authors:  K Hirai; B W Calnek
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

8.  Transformation of T-lymphocyte subsets by Marek's disease herpesvirus.

Authors:  K A Schat; C L Chen; B W Calnek; D Char
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Authors:  Benedikt B Kaufer; Sascha Trapp; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

10.  Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen.

Authors:  X F Liu; L F Lee
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.